Friendly reminder.

Back in April we learned from a large NCDB/SEER analysis that women with the lowest oncotype breast cancer recurrence score derive the greatest benefit from adjuvant post-mastectomy radiation. So, while we’re TAILORing back the chemo for this population, locoregional therapy may become more important than ever. | QuadShot Team, QuadShot 2018